About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and – more... 

Claimed Profile
Headquarters
Cambridge, Massachusetts
Revenue
more than $10bn (CAD)
Employees
5,001 to 10,000
Industry
Links
Biogen website

Twitter